BANK OF MONTREAL /CAN/ - CHEMOCENTRYX INC ownership

CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 71 filers reported holding CHEMOCENTRYX INC in Q1 2016. The put-call ratio across all filers is 9.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of CHEMOCENTRYX INC
ValueSharesWeighting
Q3 2022$422,000
+98.1%
8,155
-0.6%
0.00%
Q2 2022$213,000
-2.7%
8,204
-6.5%
0.00%
Q1 2022$219,000
-31.8%
8,778
+1.2%
0.00%
Q4 2021$321,000
-82.9%
8,675
-91.0%
0.00%
-100.0%
Q3 2021$1,881,000
+40.0%
96,150
+1.0%
0.00%0.0%
Q2 2021$1,344,000
-69.4%
95,209
+6.3%
0.00%
-66.7%
Q1 2021$4,399,000
-26.2%
89,554
-6.3%
0.00%
-25.0%
Q4 2020$5,957,000
+3980.1%
95,573
+3766.2%
0.00%
Q3 2020$146,000
-34.5%
2,472
-34.5%
0.00%
Q2 2020$223,000
+4360.0%
3,775
+2826.4%
0.00%
Q1 2020$5,000
-97.8%
129
-97.7%
0.00%
Q4 2019$223,000
+829.2%
5,623
+57.6%
0.00%
Q3 2019$24,000
-96.7%
3,568
-95.5%
0.00%
-100.0%
Q2 2019$733,000
-57.3%
78,890
-36.2%
0.00%0.0%
Q1 2019$1,717,000
+21.9%
123,643
-4.2%
0.00%0.0%
Q4 2018$1,408,000
-14.8%
129,083
-1.2%
0.00%0.0%
Q3 2018$1,652,000
+20.5%
130,682
+25.5%
0.00%0.0%
Q2 2018$1,371,000
+826.4%
104,104
+861.4%
0.00%
Q1 2018$148,000
+89.7%
10,828
-17.5%
0.00%
Q4 2017$78,000
-20.4%
13,1320.0%0.00%
Q3 2017$98,000
-3.9%
13,132
+19.4%
0.00%
Q2 2017$102,000
-29.2%
10,994
-65.7%
0.00%
Q2 2016$144,000
+1340.0%
32,059
+689.4%
0.00%
Q1 2016$10,000
-16.7%
4,061
+178.7%
0.00%
Q4 2015$12,000
-82.4%
1,457
-85.4%
0.00%
Q4 2014$68,000
+1600.0%
10,000
+1462.5%
0.00%
Q2 2014$4,0006400.00%
Other shareholders
CHEMOCENTRYX INC shareholders Q1 2016
NameSharesValueWeighting ↓
Tri Locum Partners LP 436,300$15,886,0006.25%
TANG CAPITAL MANAGEMENT LLC 500,000$18,205,0003.66%
Integral Health Asset Management, LLC 200,000$7,282,0002.02%
Sofinnova Investments, Inc. 731,222$26,624,0001.56%
Lisanti Capital Growth, LLC 231,035$8,412,0001.22%
Darwin Global Management, Ltd. 161,802$5,891,0000.90%
Cormorant Asset Management, LP 400,000$14,564,0000.87%
Perceptive Advisors 2,830,892$103,072,0000.80%
Avidity Partners Management LP 644,400$23,463,0000.50%
Eventide Asset Management 1,040,000$37,866,0000.48%
View complete list of CHEMOCENTRYX INC shareholders